Transcultural and Psychometric Validation of SUSHI and HOOS-12 Scores in Patients With Coxofemoral Pathologies
HIP
1 other identifier
observational
120
2 countries
3
Brief Summary
The management of coxofemoral pathologies is constantly increasing. In addition to degenerative hip pathology, the orthopedic surgeon is now confronted with pathologies such as femoro-acetabular conflict, pathologies of the gluteus medius and pathologies of the labrum whose early management limits arthritis degeneration. These pathologies are mainly encountered in young subjects (\<60 years). Self-questionnaires play an important role in understanding patients' point of view on the impact of their coxofemoral pathologies and also allow an assessment of their condition after treatment. For the evaluation of coxofemoral pathologies in the young subject (\<60 years) the Super Simple Hip score (SUSHI-score) was developed and validated. In the elderly subject with hip osteoarthritis, the HOOS score has the advantage of specifically measuring pain, symptoms, function and quality of life, but is made up of 40 items and is often considered rather heavy to submit. However, it has recently been simplified and the HOOS-12 (HOOS score with 12 items) has been developed and validated. These two scores are useful in current clinical practice but they are only validated in English.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 9, 2020
CompletedFirst Posted
Study publicly available on registry
July 14, 2020
CompletedStudy Start
First participant enrolled
September 11, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2023
CompletedJune 13, 2022
December 1, 2021
2 years
July 9, 2020
June 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Transcultural validation of the SUSHI-score and HOOS-12 score questionnaire
It will be a question of obtaining a version translated into French. The translated version tested on a small group of patients (15) will be submitted to the author of the original version of the tool, along with a report highlighting and explaining all the modifications and difficulties noted by a group of experts.
1 month
Psychometric validation of the SUSHI-score and HOOS-12 score questionnaire
Questionnaires will be passed by 120 subjects. Following parameters will be measured: feasibility and acceptability, validity, reliability, and sensitivity to change.
12 months
Study Arms (1)
Patients with coxofemoral pathologies
For the transcultural validation, a french version of the 2 self-assessment questionnaires, SUSHI-score and the HOOs-12 score will be produced. For the psychometric validation, 120 patients with coxofemoral pathologies will pass the two questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.
Interventions
120 patients with coxofemoral pathologies will pass the SUSHI-score and the HOOS-12 score questionnaires. The HAGOS (Hip and Groin Score) questionnaire will be also passed by the subject, for the convergent validity.
Eligibility Criteria
Patients with a coxofemoral pathology.
You may qualify if:
- Adult patient (age greater than or equal to 18 years old),
- Patient with coxofemoral pathology,
- Patient having been informed of the research,
- Patient agreeing to participate in the study.
You may not qualify if:
- Minor patient,
- Pregnant woman,
- Patient out of state to agree to participate in the study,
- Patient unable to answer a self-assessment questionnaire,
- Patient under justice, guardianship or curatorship,
- Patient who refused to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Center of Martiniquelead
- Lariboisière Hospitalcollaborator
- Saint-Gregoire Private Hospital Centercollaborator
Study Sites (3)
Hôpital Lariboisière - AP-HP
Paris, 75010, France
Centre Hospitalier Privé Saint-Grégoire
Saint-Grégoire, 35760, France
CHU of Martinique
Fort-de-France, 97261, Martinique
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2020
First Posted
July 14, 2020
Study Start
September 11, 2020
Primary Completion
September 1, 2022
Study Completion
March 1, 2023
Last Updated
June 13, 2022
Record last verified: 2021-12
Data Sharing
- IPD Sharing
- Will not share